Cellulose acetate (CA) is a semisynthetic, biodegradable polymer. Due to its characteristics, CA has several applications, including water membranes, filament-forming matrices, biomedical nanocomposites, household tools, and photographic films. This review deals with topics related to the CA membranes, which are prepared using different techniques, such as the phase inversion technique. CA membranes are considered very important since they can be used as microfiltration membranes (MF), ultrafiltration membranes (UF), nanofiltration membranes (NF), reverse osmosis (RO) membranes, and forward osmosis (FO) membranes. Membrane fouling results from the accumulation of materials that the membrane rejects on the surface or in the membrane’s pores, lowering the membrane’s flux and rejection rates. There are various forms of CA membrane fouling, for instance, organic, inorganic, particulate fouling, and biofouling. In this review, strategies used for CA membrane antifouling are discussed and summarized into four main techniques: feed solution pretreatment, cleaning of the membrane surface, membrane surface modification, which can be applied using either nanoparticles, polymer reactions, surface grafting, or surface topography, and surface coating.

The present work deals with the fabrication of novel poly(vinylidene fluoride) (PVDF)/Multi-wall Carbon Nanotubes (MWCNT)/Polypyrrole (PPy) ultrafiltration membrane by phase inversion technique for the removal of crude oil from refinery wastewater. In situ polymerization of pyrrole with different concentrations of MWCNT ranging from 0.025 wt.% to 0.3 wt.% in PVDF prepared solutions. Measurement of permeability, porosity, contact angle, tensile strength, zeta potential, rejection studies and morphological characterization by scanning electron microscopy (SEM) were conducted. The results showed that membrane with (0.05% MWCNT) concentration had the highest permeability flux (850 LMH/bar), about 17 folds improvement of permeability compared to pristine PVDF membrane. Moreover, membrane rejection of crude oil reached about 99.9%. The excellent performance of this nanocomposite membrane suggests that novel PVDF modification with polypyrrole had a considerable effect on permeability with high potential for use in the treatment of oily wastewater in the refinery industry.

Anti-nucleolin (NCL) aptamer AS1411 is the first anticancer aptamer tested in clinical trials. Gold nanoparticles (AuNP) have been widely exploited for various biomedical applications due to their unique functional properties. In this study, we evaluated the colloidal stability and targeting capacity of AS1411-funtionalized AuNP (AuNP/NCL-Apt) against MCF-7 breast cancer cell line before and after lyophilization. Trehalose, mannitol, and sucrose at various concentrations were evaluated to determine their cryoprotection effects. Our results indicate that sucrose at 10 % (w/v) exhibits the best cryoprotection effect and minimal AuNP/NCL-Apt aggregation as confirmed by UV-Vis spectroscopy and dynamic light scattering (DLS) measurements. Moreover, the lyophilized AuNP/NCL-Apt at optimized formulation maintained its targeting and cytotoxic functionality against MCF-7 cells as proven by the cellular uptake assays utilizing flow cytometry and confocal laser scanning microscopy (CLSM). Quantitative PCR (qPCR) analysis of nucleolin-target gene expression also confirmed the effectiveness of AuNP/NCL-Apt. This study highlights the importance of selecting the proper type and concentration of cryoprotectant in the typical nanoparticle lyophilization process and contributes to our understanding of the physical and biological properties of functionalized nanoparticles upon lyophilization.

Nanoparticle modification demonstrates a remarkable synergetic effect in combating bacteria, particularly resistant bacteria, enhancing their efficacy by simultaneously targeting multiple cellular pathways. This approach positions them as a potent solution against the growing challenge of antimicrobial-resistant (AMR) strains. This research presents an investigation into the synthesis, characterization, and antibacterial evaluation of silver-coordinated chloro-fullerenes nanoparticles (Ag-C₆₀-Cl) and copper-coordinated chloro-fullerenes nanoparticles (Cu-C₆₀-Cl). Utilizing an innovative, rapid one-step synthesis approach, the nanoparticles were rigorously characterized using X-ray Photoelectron Spectroscopy (XPS), Scanning Electron Microscopy-Energy Dispersive X-ray Spectrometer (SEM-EDS), High-Resolution Transmission Electron Microscopy (HR-TEM), Fourier-Transform Infrared Spectroscopy (FTIR), and Raman spectroscopy. In conjunction with the analytical techniques, a computational approach was utilized to corroborate the findings from Raman spectroscopy as well as the surface potential of these nanoparticles. Moreover, the antibacterial activities of the synthesized nanoparticles were assessed against Escherichia coli (E. coli) and Methicillin-Resistant Staphylococcus aureus (MRSA). These findings demonstrated that the synthesized Ag-C₆₀-Cl and Cu-C₆₀-Cl nanoparticles exhibited minimum inhibitory concentrations (MIC) of 3.9 μg mL⁻¹ and 125 μg mL⁻¹, respectively. Reactive oxygen species (ROS) quantification, catalase assay, and efflux pump inhibition results revealed promising broad-spectrum antibacterial effects.

Doxorubicin is used and highly effective chemotherapeutic agent; however, its clinical utility remains limited by dose‐dependent cardiotoxicity, presenting a significant challenge in cancer management. Growing preclinical research and clinical evidence suggest that the antioxidant vitamin C (ascorbic acid) may confer cardioprotective effects against doxorubicin‐induced cardiotoxicity. In this review, both preclinical and clinical research has been synthesized to assess the potential role of vitamin C in mitigating doxorubicin‐induced cardiotoxicity. Preclinical data have routinely indicated that vitamin C can reduce oxidative stress, preserve mitochondrial function, and modulate proinflammatory cytokine levels. Additionally, animal models have demonstrated promising results in maintaining cardiomyocyte structural integrity. In this capacity, vitamin C may be an effective adjunctive therapeutic for attenuating cardiac injury. Conversely, the clinical data remain variable, with emerging evidence supporting the notion that vitamin C can serve as a safe adjunct that preserves cardiac function during anthracycline therapy. Further investigation is warranted to optimize dosing, timing, and delivery routes and better elucidate the exact molecular mechanisms of these protective effects. This review emphasizes key molecular mechanisms, such as oxidative and nitrosative stress, mitochondrial dysfunction, and inflammatory signaling, in the myocardium, and examines the role of vitamin C supplementation, alone or in combination with doxorubicin, on myocardial damage markers and cardiomyocyte viability.